Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease

2019 ◽  
Vol 47 (1) ◽  
pp. 191-200
Author(s):  
Marco Calabrò ◽  
Laura Mandelli ◽  
Concetta Crisafulli ◽  
Stefano Porcelli ◽  
Diego Albani ◽  
...  
2020 ◽  
Vol 47 (3) ◽  
pp. 2415-2415
Author(s):  
Marco Calabrò ◽  
Laura Mandelli ◽  
Concetta Crisafulli ◽  
Stefano Porcelli ◽  
Diego Albani ◽  
...  

2019 ◽  
Vol 29 ◽  
pp. S202-S203
Author(s):  
Concetta Crisafulli ◽  
Marco Calabrò ◽  
Laura Mandelli ◽  
Stefano Porcelli ◽  
Diego Albani ◽  
...  

2017 ◽  
Vol 27 ◽  
pp. S438
Author(s):  
Alessandro Serretti ◽  
Stefano Porcelli ◽  
Marco Calabrò ◽  
Concetta Crisafulli ◽  
Antonios Politis ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Tânia Regina Ferreira ◽  
Luciane Cruz Lopes ◽  
Cristiane de Càssia Bergamaschi

Background: There is lack of national studies that assess the risks associated with the drugs provided under the Brazilian public health system for treating Alzheimer’s disease. Then, this study determined the prevalence and severity of self-reported adverse drug reactions (ADRs) prescribed to patients with Alzheimer’s disease in the Brazilian public health system.Methods: A cross-sectional study was carried out based on public data from the MEDEX system (information on dispensing data, known as exceptional dispensing medications) and interviews with patients and/or caregivers who get access to Alzheimer’s drugs at a public pharmacy in a large Brazilian city, between July and September 2017, inquiring about ADRs and serious adverse events (SAEs).Results: The subjects were asked about ADRs and SAEs related to the use of donepezil, galantamine, rivastigmine and memantine. Out of 285 patients enrolled on the database, 250 participated in the study (87.7%). Among the participants, approximately 63.0% were female, 70.3% aged ≥75 years and 70.3% had comorbidities. Overall, 209 patients (83.6%) reported at least one ADR (total 1,149 ADRs) and rivastigmine was associated with the largest number of ADRs per patient (7.9 ADRs/patient). The predominant adverse effects were psychiatric disorders with common frequency (57.1%) and mild severity (89.0%). Six patients (2.4%) had SAEs that required hospitalization. The use of antipsychotics was the variable associated with ADR (OR = 4.95; 95% CI: 1.45–16.93; p = 0.011).Conclusion: There was a large number of reported ADRs and most of them were of common frequency and mild severity, being mainly related to psychiatric disorders. Considering the fragility of these patients, it is important to improve safety-related care in the use of drugs for treating this disease.


2011 ◽  
Vol 491 (1) ◽  
pp. 83-86 ◽  
Author(s):  
Nan-Nan Yu ◽  
Jin-Tai Yu ◽  
Jian-Ting Xiao ◽  
Hao-Wen Zhang ◽  
Rui-Chun Lu ◽  
...  

Author(s):  
Rebecca McKnight ◽  
Jonathan Price ◽  
John Geddes

Organic psychiatric disorders result from brain dys­function caused by organic pathology inside or outside the brain. Dementia is the most common condition, with Alzheimer’s disease alone affecting 1 per cent of the population at 60 years, rising to 40 per cent over 80 years. Many of the rarer organic psychiatric dis­orders tend to affect a wider age range, but present in similar ways. Given the changing demographics of most developed countries, disorders producing cognitive im­pairment in older adults are becoming increasingly important for provision of healthcare services and in daily clinical practice. This chapter will cover the more common causes of cognitive impairment, and there is additional information in Chapters 18 and 20 on psych­iatry of older adults in psychiatry and medicine. There are three common clinical presentations of or­ganic psychiatric disorders: … 1 Delirium— an acute generalized impairment of brain function, in which the most important feature is impairment of consciousness. The disturbance of brain function is generalized, and the primary cause is often outside the brain; for example, sepsis due to a urinary tract infection. 2 Dementia— chronic generalized impairment, in which the main clinical feature is global intellectual impairment. There are also changes in mood and behaviour. The brain dysfunction is generalized, and the primary cause is within the brain; for example, a degenerative condition such as Alzheimer’s disease. 3 Specific syndromes— which include disorders with a predominant impairment of isolated areas; for example, memory (amnesic syndrome), thought, mood, or personality change. These include neurological disorders that frequently result in organic psychological complications; for example, epilepsy…. Table 26.1 lists the main categories of psychiatric disorder associated with organic brain disease. The following sections describe these syndromes and the psychiatric consequences of a number of neurological conditions. Organic causes of other core psychiatric conditions (e.g. anxiety and psychosis) are covered in the relevant specific chapters. Delirium is characterized by an acute impairment of consciousness producing a generalized cognitive impairment. The word delirium is derived from the Latin, ‘lira’, which means to wander from the furrow. Delirium is a common condition, affecting up to 30 per cent of patients in general medical or surgical wards, with the primary cause often being a sys­temic illness. The term ‘acute confusional state’ is a synonym for delirium.


2020 ◽  
Vol 12 (4) ◽  
pp. 557-575 ◽  
Author(s):  
Ahmad Mobed ◽  
Mohammad Hasanzadeh ◽  
Ali Ahmadalipour ◽  
Ali Fakhari

Neurotransmitters are the most important messengers of the nervous system, and any changes in their balances and activities can cause serious neurological, psychiatric and cognitive disorders such as schizophrenia, Alzheimer's disease and Parkinson's disease.


2010 ◽  
Vol 6 ◽  
pp. S193-S193
Author(s):  
Emma R.L.C. Vardy ◽  
Kristelle Brown ◽  
Cheryl L. Stopford ◽  
Noor Kalsheker ◽  
David Neary ◽  
...  

2009 ◽  
Vol 1264 ◽  
pp. 1-6 ◽  
Author(s):  
Heike Kölsch ◽  
Frank Jessen ◽  
Jens Wiltfang ◽  
Piotr Lewczuk ◽  
Martin Dichgans ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document